[Use of prodigiozan in the complex therapy of burns].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000906:Antibodies / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001770:Blood Bactericidal Activity / Q000187:drug effects; D002056:Burns / Q000150:complications / Q000201:enzymology / Q000276:immunology / Q000401:mortality / Q000601:surgery; D002648:Child; D003165:Complement System Proteins / Q000032:analysis; D004352:Drug Resistance, Microbial; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008875:Middle Aged; D009113:Muramidase / Q000097:blood; D010309:Parotitis / Q000188:drug therapy / Q000209:etiology; D010587:Phagocytosis / Q000187:drug effects; D011014:Pneumonia / Q000188:drug therapy / Q000209:etiology; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology; D012706:Serratia marcescens; D013203:Staphylococcal Infections / Q000188:drug therapy; D013268:Stimulation, Chemical
D000906:Antibodies; D000970:Antineoplastic Agents; D011135:Polysaccharides, Bacterial; D003165:Complement System Proteins; D009113:Muramidase
Primenenie prodigiozana v kompleksnom lechenii obozhzhennykh.